JOUD HAJJAR to Antibodies, Monoclonal
This is a "connection" page, showing publications JOUD HAJJAR has written about Antibodies, Monoclonal.
Connection Strength
0.489
-
Biomarkers of response to immune checkpoint blockade in cancer treatment. Crit Rev Oncol Hematol. 2018 Oct; 130:108-120.
Score: 0.395
-
Incidence of immune-related adverse events and its association with treatment outcomes: the MD Anderson Cancer Center experience. Invest New Drugs. 2018 08; 36(4):638-646.
Score: 0.094